Association between pro-inflammatory cytokines in cerebrospinal fluid and headache in patients with aneurysmal subarachnoid hemorrhage
暂无分享,去创建一个
[1] U. Wüllner,et al. The patients’ perspective on the burden of idiopathic intracranial hypertension , 2021, The Journal of Headache and Pain.
[2] S. Blackburn,et al. α7-Acetylcholine Receptor Signaling Reduces Neuroinflammation After Subarachnoid Hemorrhage in Mice , 2021, Neurotherapeutics.
[3] P. Kochanek,et al. CSF lipocalin-2 increases early in subarachnoid hemorrhage are associated with neuroinflammation and unfavorable outcome , 2021, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[4] Xinggen Fang,et al. Interleukin-6 in Cerebrospinal Fluid Small Extracellular Vesicles as a Potential Biomarker for Prognosis of Aneurysmal Subarachnoid Haemorrhage , 2021, Neuropsychiatric disease and treatment.
[5] A. Assiri,et al. Elevated Expression Levels of Lung Complement Anaphylatoxin, Neutrophil Chemoattractant Chemokine IL-8, and RANTES in MERS-CoV-Infected Patients: Predictive Biomarkers for Disease Severity and Mortality , 2021, Journal of Clinical Immunology.
[6] Yasuo Watanabe,et al. Sequential expression of neutrophil chemoattractants in cerebrospinal fluid after subarachnoid hemorrhage , 2021, Journal of Neuroimmunology.
[7] P. Vajkoczy,et al. Microglia as target for anti-inflammatory approaches to prevent secondary brain injury after subarachnoid hemorrhage (SAH) , 2021, Journal of neuroinflammation.
[8] M. Simon,et al. Interleukin 6 in cerebrospinal fluid is a biomarker for delayed cerebral ischemia (DCI) related infarctions after aneurysmal subarachnoid hemorrhage , 2021, Scientific reports.
[9] Cameron R. Smith,et al. Pterygopalatine Fossa Blockade as Novel, Narcotic-Sparing Treatment for Headache in Patients with Spontaneous Subarachnoid Hemorrhage , 2021, Neurocritical Care.
[10] K. Arai,et al. Soluble vascular endothelial-cadherin in CSF after subarachnoid hemorrhage , 2020, Neurology.
[11] Haiying Li,et al. Systemic exosomal miR-193b-3p delivery attenuates neuroinflammation in early brain injury after subarachnoid hemorrhage in mice , 2020, Journal of Neuroinflammation.
[12] M. Westphal,et al. The burden of headache following aneurysmal subarachnoid hemorrhage: a prospective single-center cross-sectional analysis , 2020, Acta Neurochirurgica.
[13] I. Stiell,et al. Prospective Implementation of the Ottawa Subarachnoid Hemorrhage Rule and 6-Hour Computed Tomography Rule , 2019, Stroke.
[14] Dong H. Kim,et al. Inflammation in delayed ischemia and functional outcomes after subarachnoid hemorrhage , 2019, Journal of Neuroinflammation.
[15] S. Homer-Vanniasinkam,et al. Compartmentalisation of the inflammatory response following aneurysmal subarachnoid haemorrhage. , 2019, Cytokine.
[16] C. Wirtz,et al. Quality of Life After Treatment of Unruptured Intracranial Aneurysms. , 2019, World neurosurgery.
[17] R. Ji,et al. Roles of inflammation, neurogenic inflammation, and neuroinflammation in pain , 2018, Journal of Anesthesia.
[18] R. Macdonald,et al. Incorporating a Modified Graeb Score to the Modified Fisher Scale for Improved Risk Prediction of Delayed Cerebral Ischemia Following Aneurysmal Subarachnoid Hemorrhage , 2018, Neurosurgery.
[19] Qi Wu,et al. Levels of Interleukin-1β, Interleukin-18, and Tumor Necrosis Factor-α in Cerebrospinal Fluid of Aneurysmal Subarachnoid Hemorrhage Patients May Be Predictors of Early Brain Injury and Clinical Prognosis. , 2017, World neurosurgery.
[20] H. Vatter,et al. Elevated Systemic IL-6 Levels in Patients with Aneurysmal Subarachnoid Hemorrhage Is an Unspecific Marker for Post-SAH Complications , 2017, International journal of molecular sciences.
[21] M. Smrčka,et al. Early Dynamics of Interleukin-6 in Cerebrospinal Fluid after Aneurysmal Subarachnoid Hemorrhage , 2017, Journal of Neurological Surgery Part A: Central European Neurosurgery.
[22] J. Briegel,et al. Interleukin 6 in the Cerebrospinal Fluid as a Biomarker for Onset of Vasospasm and Ventriculitis After Severe Subarachnoid Hemorrhage. , 2017, World neurosurgery.
[23] A. Gottschalk,et al. The Longitudinal Course of Pain and Analgesic Therapy Following Aneurysmal Subarachnoid Hemorrhage: A Cohort Study , 2016, Headache.
[24] K. Osuka,et al. Interleukin-6, MCP-1, IP-10, and MIG are sequentially expressed in cerebrospinal fluid after subarachnoid hemorrhage , 2016, Journal of Neuroinflammation.
[25] Gang Zhao,et al. Elevated IL-6 and TNF-α Levels in Cerebrospinal Fluid of Subarachnoid Hemorrhage Patients , 2016, Molecular Neurobiology.
[26] R. Ecker,et al. Inadequacy of Headache Management After Subarachnoid Hemorrhage. , 2016, American journal of critical care : an official publication, American Association of Critical-Care Nurses.
[27] D. Hodge,et al. Safety and Tolerability of Gabapentin for Aneurysmal Subarachnoid Hemorrhage (SAH) Headache and Meningismus , 2014, Neurocritical Care.
[28] Michael Forsting,et al. European Stroke Organization Guidelines for the Management of Intracranial Aneurysms and Subarachnoid Haemorrhage , 2013, Cerebrovascular Diseases.
[29] Paul Vespa,et al. Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association , 2012, Stroke.
[30] O. Sakowitz,et al. High ICP as trigger of proinflammatory IL-6 cytokine activation in aneurysmal subarachnoid hemorrhage , 2010, Neurological research.
[31] G. Rinkel,et al. Magnesium and headache after aneurysmal subarachnoid haemorrhage , 2009, Journal of Neurology, Neurosurgery & Psychiatry.
[32] T. Gasser,et al. ANALYSIS OF INTRATHECAL INTERLEUKIN‐6 AS A POTENTIAL PREDICTIVE FACTOR FOR VASOSPASM IN SUBARACHNOID HEMORRHAGE , 2007, Neurosurgery.
[33] G. Marquardt,et al. Long term follow up after perimesencephalic subarachnoid haemorrhage , 2000, Journal of neurology, neurosurgery, and psychiatry.
[34] F. Tancioni,et al. Cisternal CSF levels of cytokines after subarachnoid hemorrhage. , 1998, Neurological research.